Search results for "FAILURE"

showing 10 items of 1977 documents

Double-blind cross-over study with oral alpha-ketoacids in patients with chronic renal failure.

1980

In 15 ambulatory patients with renal insufficiency (creatinine clearance, 9.9 +/- 3.0 ml/min) the effect of oral supplementation with alpha-ketoacids has been compared with that of placebo. The protein intake amounted to 0.55 g protein per kilogram body weight of high biological value, as estimated by dietary recordings. After a control period of 3 months the patients received, in a double-blind study, 1.05 g alpha-ketoacids/10 kg body weight per day or a placebo for 6 weeks with a subsequent cross-over. Fasting blood samples were analyzed at 3-week intervals for routine laboratory parameters and 17 proteins. Anthropometric and clinical data have been recorded every 3 weeks. While therapy w…

AdultMalemedicine.medical_specialtyMedicine (miscellaneous)Renal functionAlpha (ethology)PlaceboGastroenterologyPhosphatesPlacebosElectrolytesDouble-Blind MethodInternal medicinemedicineHumansClinical Trials as TopicNutrition and Dieteticsbusiness.industrynutritional and metabolic diseasesBiological valueBlood ProteinsAnthropometryMiddle AgedCrossover studyKeto AcidsDietClinical trialEndocrinologyCreatinineAmbulatoryKidney Failure ChronicFemalebusinessThe American journal of clinical nutrition
researchProduct

Association of elevated serum triglyceride levels with a more severe course of acute pancreatitis: Cohort analysis of 1457 patients.

2019

Previous publications have reported an association between hypertriglyceridemia (HTG) and severity of acute pancreatitis, but this relationship remains somewhat controversial.To evaluate the outcome of acute pancreatitis according to serum triglyceride levels on admission.Retrospective analysis of prospectively collected data, which included all consecutive cases of acute pancreatitis admitted to a tertiary hospital (January 2002-December 2014). Acute pancreatitis patients were classified into 3 groups based on serum triglyceride levels (mg/dl) measured within 48 h from admission: normal triglycerides-mild HTG (200); moderate HTG (200-749); severe HTG (≥750). Primary outcomes were the diffe…

AdultMalemedicine.medical_specialtyMultivariate analysisNecrosisAdolescentEndocrinology Diabetes and MetabolismMultiple Organ FailureGastroenterologyCohort Studies03 medical and health scienceschemistry.chemical_compoundYoung Adult0302 clinical medicineRisk FactorsInternal medicinemedicineHumansPancreasTriglyceridesAgedRetrospective StudiesAged 80 and overHypertriglyceridemiaHepatologyTriglyceridebusiness.industryPancreatitis Acute NecrotizingHypertriglyceridemiaGastroenterologyMiddle Agedmedicine.diseasePrognosisTreatment OutcomechemistryPancreatitis030220 oncology & carcinogenesisAcute DiseaseAcute pancreatitisPancreatitis030211 gastroenterology & hepatologyFemalemedicine.symptomSevere coursebusinessCohort studyPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
researchProduct

Reliability of knee extension and flexion measurements using the Con-Trex isokinetic dynamometer.

2007

The aim of this study was to evaluate the reliability of isokinetic and isometric assessments of the knee extensor and the flexor muscle function using the Con-Trex isokinetic dynamometer. Thirty healthy subjects (15 males, 15 females) were tested and retested 7 days later for maximal strength (isokinetic peak torque, work, power and angle of peak torque as well as isometric maximal voluntary contraction torque and rate of torque development) and fatigue (per cent loss and linear slope of torque and work across a series of 20 contractions). For both the knee extensor and the flexor muscle groups, all strength data - except angle of peak torque - demonstrated moderate-to-high reliability, wi…

AdultMalemedicine.medical_specialtyMuscle Strength DynamometerWork outputKnee JointPhysiologyIntraclass correlationPhysical ExertionIsometric exerciseMuscle Strength DynamometerSensitivity and SpecificityPhysical medicine and rehabilitationPhysiology (medical)medicineHumansMuscle StrengthRange of Motion ArticularMuscle SkeletalMuscle fatiguebusiness.industryWork (physics)Reproducibility of ResultsGeneral MedicineEquipment Designmusculoskeletal systemEquipment Failure AnalysisPhysical therapyFemaleRange of motionbusinessHamstringClinical physiology and functional imaging
researchProduct

Comparison of tumour necrosis factor and endothelin-1 between essential and renal hypertensive patients

1998

The present study was performed to compare circulating levels of tumour necrosis factor-alpha (TNFalpha) and plasma endothelin 1 (ET-1), of hypertensive patients with or without renal failure and with those of normotensive healthy subjects. The study population consisted of 21 healthy normotensive subjects and 22 hypertensive patients, 11 with essential hypertension, and 11 with hypertension and chronic renal failure (CRF). Plasma ET-1 levels, serum TNFalpha and creatinine, creatinine clearance, 24-h urinary albumin excretion (UAE) were assayed, and 24-h blood pressure monitoring was obtained in all subjects. Office blood pressure was similar between hypertensive patients with and without C…

AdultMalemedicine.medical_specialtyNecrosisRenal functionEssential hypertensionGastroenterologyExcretionchemistry.chemical_compoundInternal medicineInternal MedicinemedicineAlbuminuriaHumansCreatinineEndothelin-1Tumor Necrosis Factor-alphabusiness.industryBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseaseEndothelin 1Hypertension RenovascularBlood pressureEndocrinologychemistryCreatinineHypertensionKidney Failure ChronicFemalemedicine.symptombusinessKidney diseaseJournal of Human Hypertension
researchProduct

Behaviour of carbonyl groups in several clinical conditions: Analysis of our survey

2019

Protein carbonylation is a marker of oxidative protein damage, that is likely involved in the pathogenesis of several diseases. The aim of this study was to evaluate the protein carbonyl (PC) groups in different clinical conditions. It included different groups of subjects: 81 trained subjects; 23 subjects with mild essential hypertension; 31 middle-aged subjects with metabolic syndrome (MS); 106 subjects with MS not selected for age (subdivided into two subgroups, with and without diabetes mellitus); 91 obese adults subdivided in two subgroups (BMI 30-35 Kg/m2 and BMI > 35 kg/m2); 48 subjects with obstructive sleep apnea syndrome (OSAS) subdivided in accordance with the apnea/hypopnea i…

AdultMalemedicine.medical_specialtyOxidative stress arterial hypertension metabolic syndrome juvenile myocardial infarction chronic kidney failurePhysiologymedicine.medical_treatment030204 cardiovascular system & hematologyEssential hypertension030218 nuclear medicine & medical imagingProtein Carbonylation03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesPhysiology (medical)Internal medicineDiabetes mellitusmedicineHumansDiseaseMyocardial infarctionDialysisbusiness.industryHematologymedicine.diseaseObstructive sleep apneaFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessOxidation-ReductionHypopneaBiomarkersKidney diseaseClinical Hemorheology and Microcirculation
researchProduct

End-of-life situations in cardiology: a qualitative study of physicians' and nurses' experience in a large university hospital.

2018

IF 2.335 (2-year Impact Factor); International audience; Background: rofessional societies call for integration of end-of-life discussions early in the trajectory of heart failure, yet it remains unclear where current practices stand in relation to these recommendations. We sought to describe the perceptions and attitudes of caregivers in cardiology regarding end-of-life situations.Methods: e performed a qualitative study using semi-directive interviews in the cardiology department of a university teaching hospital in France. Physicians, nurses and nurses’ aides working full-time in the department at the time of the study were eligible. Participants were asked to describe how they experienc…

AdultMalemedicine.medical_specialtyPalliative careAttitude of Health Personnellcsh:Special situations and conditionsClinical Decision-MakingPsychological interventionCardiologyContext (language use)Legislation030204 cardiovascular system & hematologyNursing Staff Hospital03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemProfessional-Family RelationsInternal medicinemedicineHumans030212 general & internal medicineQualitative ResearchHeart FailureTerminal Carelcsh:RC952-1245Palliative CareGeneral MedicineProfessional-Patient RelationsMiddle Aged[SDV.ETH] Life Sciences [q-bio]/Ethics[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system[SDV.ETH]Life Sciences [q-bio]/Ethics3. Good healthDistressHospitalistsCardiologyDisease ProgressionProfessional associationFemaleInterdisciplinary CommunicationCardiology Service HospitalFranceThematic analysisPsychologyAdvance DirectivesQualitative researchResearch ArticleEnd-of-lifeBMC palliative care
researchProduct

Metastatic instability at the proximal end of the femur

1994

A retrospective study was performed of the surgical treatment of metastatic lesions of the proximal femur in 50 patients. In 25 consecutive cases a megaprosthesis was implanted; compound plate osteosynthesis was performed in another 25 consecutive patients. Indications for surgical treatment were pathological fractures or, for prophylactic treatment, lesions of the femoral cortex exceeding 2.5 cm in diameter or affecting half the diameter of the bone or more. In all patients capable of walking preoperatively mobility was regained. Immediate full weight-bearing stability was obtained in all patients. Group analysis showed that the functional rating of the hip joint was unchanged, i.e., good …

AdultMalemedicine.medical_specialtyPalliative caremedicine.medical_treatmentBreast NeoplasmsProsthesisPostoperative ComplicationsOsseointegrationBone platemedicineHumansOrthopedics and Sports MedicineFemurReduction (orthopedic surgery)AgedRetrospective StudiesOsteosynthesisbusiness.industryFemoral NeoplasmsPalliative CareImplant failureGeneral MedicineMiddle AgedKidney NeoplasmsProsthesis FailureSurgeryFractures SpontaneousTreatment OutcomeOrthopedic surgeryFemaleSurgeryHip ProsthesisbusinessBone PlatesArchives of Orthopaedic and Trauma Surgery
researchProduct

Macroamylasaemia after treatment with hydroxyethyl starch

1977

After infusion of 500 ml of 6% hydroxyethyl starch into fifty-four patients an increase of serum amylase was observed which in fifty-one cases exceeded the upper limit of normal (190 U/l). In most cases serum amylase reached twice the basal value. Renal function influenced the duration of the increase in serum amylase, but not the maximum increase (201+/-15 U/l; mean+/-SEM). In patients with advanced renal failure (glomerular filtration rate (GFR) = 2-10 ml/min) serum amylase was still markedly elevated after 72 h (298+/-24 U/l; mean+/-SEM). In patients with normal renal function (GFR greater than 90 ml/min) serum amylase decreased to 183+/-40 U/l (mean+/-SEM) within 72 h without reaching b…

AdultMalemedicine.medical_specialtyPancreatic diseaseClinical BiochemistryRenal functionUrineIn Vitro TechniquesHydroxyethyl starchBiochemistryHydroxyethyl Starch DerivativesExcretionBasal (phylogenetics)Renal DialysisInternal medicinemedicineHumansInfusions ParenteralAmylaseLipasePancreasbiologyChemistryStarchGeneral MedicineMiddle Agedmedicine.diseaseEndocrinologyAmylasesHypertensionChromatography Gelbiology.proteinKidney Failure ChronicFemaleGlomerular Filtration Ratemedicine.drugEuropean Journal of Clinical Investigation
researchProduct

Pancreatic enzymes in chronic renal failure and transplant patients.

1992

The aim of the present study was to determine the frequency and degree of elevated serum levels of Total Amylase (TA), Pancreatic Amylase (PA), and Lipase (L) activity in patients with chronic renal failure (CRF) on conservative therapy; CRF on periodical hemodialysis (HD); in renal transplant (RT) and in a control Group (C). Mean values were significantly higher in all groups than Group C for TA (p < 0.005), PA (p < 0.0001) and L (p < 0.0001). A statistically significant correlation was found between TA and L vs creatininemia values in CRF patients, but only up to a certain level (creatininemia < 6 mg %) (p < 0.03 and p < 0.05), above which there was no correlation. The enzyme most frequen…

AdultMalemedicine.medical_specialtyPancreatic diseasemedicine.medical_treatmentGastroenterologyNephropathychemistry.chemical_compoundEndocrinologyRenal DialysisInternal medicinemedicineHumansPancreasDialysisAgedKidneyCreatininebusiness.industryGastroenterologyLipaseMiddle Agedmedicine.diseaseKidney TransplantationEndocrinologymedicine.anatomical_structureOncologychemistryRenal pathologyCreatinineAmylasesPancreatitisKidney Failure ChronicFemaleHemodialysisbusinessInternational journal of pancreatology : official journal of the International Association of Pancreatology
researchProduct

Parathyroid hormone is inversely related to endothelin-1 in patients on haemodialysis

2008

SUMMARY: Aim: Parathyroid hormone secretion is mainly influenced by hypocalcaemia, hyperphosphataemia and vitamin D deficiency. However, previous in vitro and in vivo studies showed that endothelin-1 can influence parathyroid hormone secretion. This study was aimed at evaluating this relationship in vivo in uraemic patients. Methods: Parathyroid hormone and endothelin-1 plasma concentrations were measured in 67 haemodialysed patients. Patients with history of cardiovascular diseases and those with parathyroid adenoma were excluded. Results: Plasma levels of endothelin-1 were found to be inversely related to those of parathyroid hormone (P < 0.04) The multiple regression analysis, carried ou…

AdultMalemedicine.medical_specialtyParathyroid hormonevitamin D deficiencyEnd stage renal diseaseRenal DialysisInternal medicinemedicineHumansHypocalcaemiachronic kidney disease dialysis end-stage renal disease endothelin-1 parathyroid hormone.AgedParathyroid adenomaEndothelin-1business.industryGeneral MedicineMiddle Agedmedicine.diseaseEndothelin 1EndocrinologyParathyroid HormoneNephrologyKidney Failure ChronicRegression AnalysisParathyroid hormone secretionFemaleSecondary hyperparathyroidismbusinessNephrology
researchProduct